Atrial fibrillation patients saw 69% lower risk with common blood thinners

Sunday, September 27, 2026

Want headlines delivered to your inbox?
Subscribe to our free daily newsletter.

Search Headlines:

Match Type:BroadStrict



Direct oral anticoagulants cut the risk of serious clinical events by 69% in atrial fibrillation patients with an intermediate risk of stroke, according to the randomized SINGLE-AF trial. The benefit was driven mainly by fewer ischemic strokes, with no increase in major bleeding. (via Science Daily)

Read the Full Story
This article will expire in 29 days.

In the News...

View All Recent News

Note: News headlines appearing on this site do not reflect the opinion of RxChat.com or its staff.